Q32 Bio (QTTB) Cash & Equivalents (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08% |
| Dec 31, 2025 | -1.51% |
| Sep 30, 2025 | -10.56% |
| Jun 30, 2025 | -16.27% |
| Mar 31, 2025 | -16.01% |
| Dec 31, 2024 | -12.48% |
| Sep 30, 2024 | -8.79% |
| Jun 30, 2024 | -15.45% |
| Mar 31, 2024 | 350.91% |
| Dec 31, 2023 | -29.34% |
| Sep 30, 2023 | 80.77% |
| Jun 30, 2023 | -36.14% |
| Mar 31, 2023 | -7.59% |
| Dec 31, 2022 | -21.26% |
| Sep 30, 2022 | -75.50% |
| Jun 30, 2022 | -28.99% |
| Mar 31, 2022 | 124.89% |
| Dec 31, 2021 | 15.14% |
| Sep 30, 2021 | -18.50% |
| Jun 30, 2021 | 11.26% |
| Mar 31, 2021 | -51.67% |
| Dec 31, 2020 | 21.99% |
| Sep 30, 2020 | 6.94% |
| Jun 30, 2020 | 15.89% |
| Mar 31, 2020 | 162.76% |
| Dec 31, 2019 | -29.02% |
| Sep 30, 2019 | -33.62% |
| Jun 30, 2019 | 177.44% |
| Mar 31, 2019 | 5.30% |
| Dec 31, 2018 | 5.72% |
| Sep 30, 2018 | -60.16% |
| Jun 30, 2018 | 97.90% |
| Mar 31, 2018 | -10.05% |
| Dec 31, 2017 | -45.44% |
| Sep 30, 2017 | 378.56% |
| Jun 30, 2017 | -22.90% |